Table 1.

Patient demographic and clinicopathological characteristics among 8523 non-Hispanic White (NHW) and Black (NHB) women diagnosed with stage I-IV breast cancer in the metropolitan Atlanta area between 2010–2014 and registered with the Georgia Cancer Registry.

	Redlining				Lending Bias
	<1		≥1		<3		≥3
Neighborhood Characteristics	N	%	N	%	N	%	N	%
Percent Black
≥50%	99	2.1	2948	76	2574	55	473	12
<50%	4553	98	923	24	2106	45	3370	88
Percent Poverty
≥20%	369	7.9	1957	49	1672	36	693	18
<20%	4283	92	1914	51	2969	64	3189	82
Percent less than Highschool Education
≥20%	124	2.7	911	26	1323	29	530	14
<20%	4528	97	2960	74	3318	71	3352	86
Medium Household Income
<$44,311	213	4.6	1915	49	1502	32	587	15
$44,311- < $61,403	774	17	1355	35	1424	30	705	18
$61,403 - <$84,497	1578	34	544	14	1157	25	1004	26
≥ $84,497	2087	45	57	1.5	597	13	1547	40
Patient Characteristics
	Median	IQR	Median	IQR	Median	IQR	Median	IQR
Age at Diagnosis (years)	58	49, 68	58	49, 67	58	49, 66	59	49, 68
Length of Follow-up (months)	44	30, 62	43	28, 61	44	28, 61	44	29, 62
Time to event (months)	23	12, 37	21	11, 33	21	12, 33	23	10, 36
	N	%	N	%	N	%	N	%
Breast Cancer-Specific Death	314	3.7	493	5.8	486	5.7	321	3.8
Race/Ethnicity
Non-Hispanic Black	721	16	2859	75	2668	57	912	24
Non-Hispanic White	3931	85	1012	26	2012	43	2931	76
Stage
I	2496	54	1628	42	2093	45	2031	53
II	1483	32	1395	36	1654	35	1224	32
III	427	9.2	522	13	586	13	363	9.4
IV	246	5.3	326	8.4	347	7.4	225	5.9
Molecular Subtype
HR+/HER2− (Luminal A)	3260	75	2325	64	2936	67	2649	74
HR+/HER2+ (Luminal B)	496	11	461	13	553	13	404	11
HR−/HER2+ (HER2 Overexpressing)	175	4.1	182	5.0	205	4.7	152	4.3
HR−/HER2− (Triple Negative)	395	9.1	652	18	683	16	364	10
Unknown	326		251		303		274
Insurance Type
Uninsured	70	1.5	131	3.4	126	2.7	75	2.0
Private	3004	65	2050	53	2686	57	2368	62
Medicaid	186	4	469	12	453	9.7	202	5.3
Medicare	1295	28	1094	28	1266	27	1123	29
Military/Other/Unknown**	97	2.5	127	3.3	149	3.1	75	1.9

^**Mostly military; N=8 Other among NHB; N=0 Other among NHW